Market revenue in 2021 | USD 110.1 million |
Market revenue in 2027 | USD 76.5 million |
Growth rate | -5.9% (CAGR from 2021 to 2027) |
Largest segment | Prefilled syringe |
Fastest growing segment | Inhalers |
Historical data covered | 2016 - 2020 |
Base year for estimation | 2021 |
Forecast period covered | 2022 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Prefilled syringe, Inhalers |
Key market players worldwide | AstraZeneca PLC ADR, Johnson & Johnson, Serum Institute of India Pvt. Ltd., GSK PLC ADR, Moderna Inc, Pfizer Inc, Bharat Biotech, PHARMAJET, Novavax Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 drug delivery devices market will help companies and investors design strategic landscapes.
Prefilled syringe was the largest segment with a revenue share of 67.21% in 2021. Horizon Databook has segmented the Latin America covid-19 drug delivery devices market based on prefilled syringe, inhalers covering the revenue growth of each sub-segment from 2016 to 2027.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America covid-19 drug delivery devices market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America covid-19 drug delivery devices market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account